ARTICLE | Company News
FDA accepts Campath BLA for filing
February 15, 2000 8:00 AM UTC
The FDA accepted the BLA for Campath, a humanized monoclonal antibody to treat advanced B cell chronic lymphocytic leukemia resistant to existing therapies. The BLA was filed by Ilex (ILXO) and Millen...